共 50 条
- [1] The effects of maintenance therapy with upadacitinib on abdominal pain, bowel urgency, and fatigue in patients with moderately to severely active Ulcerative Colitis: Phase 3 U-ACHIEVE maintenance resultsJOURNAL OF CROHNS & COLITIS, 2022, 16 : I008 - I009Danese, S.Tran, J.D'Haens, G.Rubin, D. T.Aoyama, N.Zhou, W.James, B.Yao, X.Gonzalez, Y. SanchezPanaccione, R.
- [2] Efficacy and Safety of Upadacitinib Maintenance Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Final Results From the Phase 3 U-ACHIEVE Maintenance StudyAMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S521 - S522Vermeire, SeverineDanese, SilvioZhou, WenYao, XuanIlo, DapoLiu, JohnHebuterne, XavierLindsay, JamesSanchez-Gonzalez, YuriHiggins, Peter D.Colombel, Jean-FredericPanaccione, Remo
- [3] Upadacitinib Induction and Maintenance Therapy Improves Abdominal Pain, Bowel Urgency, and Fatigue in Patients With Ulcerative Colitis: A Post Hoc Analysis of Phase 3 DataINFLAMMATORY BOWEL DISEASES, 2023, 29 (11) : 1723 - 1729Danese, SilvioTran, JacindaD'Haens, GeertRubin, David T.Aoyama, NobuoZhou, WenIlo, DapoYao, XuanSanchez Gonzalez, YuriPanaccione, Remo
- [4] The effects of upadacitinib on ulcerative colitis symptom resolution and fatigue normalization in patients with moderately to severely active ulcerative colitis: Phase 3 U-ACHIEVE and U-ACCOMPLISH resultsJOURNAL OF CROHNS & COLITIS, 2023, 17 : I27 - I29D'Haens, G.Tran, J.Danese, S.Rubin, D. T.Aoyama, N.Lugering, A.Klaff, J.Xuan, S.Ilo, D.Gonzalez, Y. SanchezPanes, J.
- [5] THE EFFECTS OF UPADACITINIB ON ULCERATIVE COLITIS SYMPTOM RESOLUTION AND FATIGUE NORMALIZATION IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: PHASE 3 U-ACHIEVE AND U-ACCOMPLISH RESULTSGASTROENTEROLOGY, 2023, 164 (06) : S1102 - S1103D'Haens, GeertTran, Jacinda N.Danese, SilvioRubin, David T.Aoyama, NobuoLugering, AndreasKlaff, JustinXuan, SiIlo, DapoGonzalez, Yuri SanchezPanes, Julian
- [6] Effects of upadacitinib on ulcerative colitis symptom resolution and fatigue normalization in patients with moderately to severely active ulcerative colitis: Phase 3 U-ACHIEVE and U-ACCOMPLISH resultsJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 137 - 138Pudipeddi, A.D'Haens, G.Tran, J.Danese, S.Rubin, D. T.Aoyama, N.Luegering, A.Klaff, J.Xuan, S.Ilo, D.Gonzalez, Y. SanchezPanes, J.
- [7] Efficacy and safety of upadacitinib induction therapy in patients with Moderately to Severely Active Ulcerative Colitis: Results from the phase 3 U-ACHIEVE studyJOURNAL OF CROHNS & COLITIS, 2021, 15 : S022 - S024Danese, S.Vermeire, S.Zhou, W.Pangan, A.Siffledeen, J.Hebuterne, X.Nakase, H.Higgins, P.Chen, M. H.Sanchez-Gonzalez, Y.Huang, B.Xie, W.Liu, J.Weinreich, M.Pannaccione, R.
- [8] Efficacy and Safety of Upadacitinib Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Results From the Phase 3 U-ACHIEVE StudyAMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S312 - S313Danese, SilvioVermeire, SeverineZhou, WenPangan, AileenSiffledeen, JesseHebuterne, XavierNakase, HiroshiChen, MinhuHiggins, PeterSanchez-Gonzalez, YuriHuang, BidanXian, WangangLiu, JianzhongWeinreich, MichaelPanaccione, Remo
- [9] Maintenance of health-related quality of life improvements with upadacitinib treatment among patients with moderately to severely active ulcerative colitis: results from, 52-week phase, 3 study U ACHIEVE maintenanceJOURNAL OF CROHNS & COLITIS, 2022, 16 : I373 - I374Panes, J.Loftus, E. V. J.Higgins, P.Lindsay, J. O.Zhou, W.Yao, X.Ilo, D.Phillips, C.Tran, J.Sanchez Gonzalez, Y.Vermeire, S.
- [10] Maintenance of health-related quality of life improvements with upadacitinib treatment among patients with moderately to severely active ulcerative colitis: results from, 52-week phase, 3 study U ACHIEVE maintenanceJOURNAL OF CROHNS & COLITIS, 2022, 16 : I373 - I374Panes, J.Loftus, E. V. J.Higgins, P.Lindsay, O.Zhou, W.Yao, X.Ilo, D.Phillips, C.Tran, J.Gonzalez, Y. SanchezVermeire, S.